Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí sinh học đề tài : An NIH intramural percubator as a model of academic-industry partnerships: from the beginning of life through the valley of death | Emmert-Buck Journal of Translational Medicine 2011 9 54 http content 9 1 54 JOURNAL OF TRANSLATIONAL MEDICINE COMMENTARY Open Access An NIH intramural percubator as a model of academic-industry partnerships from the beginning of life through the valley of death Michael R Emmert-Buck Abstract In 2009 the NIH publicly announced five strategic goals for the institutes that included the critical need to translate research discoveries into public benefit at an accelerated pace with a commitment to find novel ways to engage academic investigators in the process. The emphasis on moving scientific advancements from the laboratory to the clinic is an opportune time to discuss how the NIH intramural program in Bethesda the largest biomedical research center in the world can participate in this endeavor. Proposed here for consideration is a percolatorincubator program a percubator designed to enable NIH intramural investigators to develop new medical interventions as quickly and efficiently as possible. Introduction I have sometimes thought that in order to be a good minister it was necessary to leave the ministry. The profession is antiquated. In an altered age we worship in the dead forms of our forefathers. - Ralph Waldo Emerson The present proposal is in response to the recent call by the NIH to develop new methods that facilitate the translational research process 1-3 . At the outset it is imperative to crystallize what is being articulated - not so much a business model or administrative structure but an environment where academic percolation and business incubation occur together back and forth short-term and long-term without artificial walls of separation and where investigators are enabled to use their knowledge to rapidly move discoveries to the public. The percubator is a partnership between government and business that incorporates the best of both to responsibly but urgently translate research findings into clinical interventions.
